SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

2.

Patients With Early-Onset Cancer Unaware of Infertility Risk

3.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

4.

Inner Thoughts of Leonard Bernstein, the "Maestro".

5.

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot